Calla Health Foundation

Calla Health Foundation is a for-profit, woman-owned small business headquartered in Durham, North Carolina, registered in SAM.gov through July 28, 2026. The organization specializes in developing medical technologies and innovative healthcare solutions with a focus on global health challenges, particularly in low- and middle-income countries. As a corporate entity, Calla Health Foundation operates as a manufacturer of goods and has established itself as a strategic partner in medical technology development and implementation.

The organization has been actively engaged in federal grant work, specifically through a significant project grant from the National Cancer Institute's Cancer Detection and Diagnosis Research program, valued at $317,420. The grant focuses on developing and validating a patient-ready callascope for cervical imaging, with a primary goal of addressing cervical cancer prevention in resource-limited settings. Calla Health Foundation has collaborated closely with William Marsh Rice University on multiple sub-grant awards related to low-cost mobile colposcopy and confocal imaging technologies. Their work involves creating point-of-care solutions for screening, diagnosis, and treatment alternatives, including an automated injector, novel ethanol gel formulation for cervical precancer ablation, and AI-powered diagnostic algorithms. The project aims to dramatically increase healthcare access by shifting care from hospitals to community health workers and midwives, with a specific emphasis on reducing cervical cancer mortality in regions with limited medical infrastructure.